The European Medicines Agency review of eltrombopag (Revolade) for the treatment of adult chronic immune (idiopathic) thrombocytopenic purpura: summary of the scientific assessment of the Committee for Medicinal Products for Human Use

On 11(th) March 2010, the European Commission issued a marketing authorization valid throughout the European Union for Revolade for the treatment of adult chronic immune (idiopathic) thrombocytopenic purpura. Revolade is an orphan medicinal product indicated for splenectomized patients with immune (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nieto, Maria, Calvo, Gonzalo, Hudson, Ian, Feldschreiber, Peter, Brown, David, Lee, Ching Cheng, Lay, Geoffrey, Valeri, Anna, Abadie, Eric, Thomas, Angela, Pignatti, Francesco
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2011
Assuntos:
Online-Only Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3166089/
https://ncbi.nlm.nih.gov/pubmed/21712542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2011.048819
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados